Last update 06 Dec 2025
Edelris SAS

Edelris SAS

Private Company|2005|France|
50-100
|
www.edelris.com

Overview

Tags

Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
CLK x DYRK2
PIF1(PIF1 5'-to-3' DNA helicase)1

Related

3
Drugs associated with Edelris SAS
hPIF1 Helicase Inhibitors(Edelris)
Target
PIF1
Mechanism
PIF1 inhibitors
Active Org.
Edelris SASEdelris SAS [+1]
Originator Org.
Université Grenoble Alpes [+1]
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Leucettinibs
Target
CLK x DYRK
Mechanism
CLK inhibitors [+1]
Active Org.
Edelris SASEdelris SAS [+1]
Originator Org.
Edelris SASEdelris SAS [+1]
Active Indication-
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
Iso-Leucettinibs
Target
CLK x DYRK
Mechanism
CLK inhibitors [+1]
Active Org.
Edelris SASEdelris SAS [+1]
Originator Org.
Edelris SASEdelris SAS [+1]
Active Indication-
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Edelris SAS
Login to view more data
0 Patents (Medical) associated with Edelris SAS
Login to view more data
100 Deals associated with Edelris SAS
Login to view more data
100 Translational Medicine associated with Edelris SAS
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
hPIF1 Helicase Inhibitors(Edelris)
 ( PIF1 )		Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free